U.S. clinical trial for monkeypox antiviral, TPOXX, begins
by Press Release from Outbreak News Today on (#63F5K)
NewsDesk @bactiman63 A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators aim to enroll more than 500 people from clinical research sites nationwide. Interested volunteers can visit the ACTG website (clinical trial A5418) for more information. The trial is [...]
The post U.S. clinical trial for monkeypox antiviral, TPOXX, begins appeared first on Outbreak News Today.